Skip to main content
Top
Published in: Annals of Hematology 12/2006

01-12-2006 | Original Article

Stage-related changes in functional capacity in Hodgkin’s disease: assessment by cardiopulmonary exercise testing before initiation of treatment

Authors: Eric Page, David Assouline, Catherine Durand, Odile Brun, David Coeffic, Danièle Fric, Claire Garnier, Cécile Leyronnas, Véronique Alcalay, Bernard Aguilaniu

Published in: Annals of Hematology | Issue 12/2006

Login to get access

Abstract

Our aim was to examine indices of cardiorespiratory capacity at rest and during exercise before initiation of therapy for Hodgkin’s disease. We prospectively studied 24 patients divided into two groups according to the disease stage. Group 1 included eight patients in stage IA and four in stage IIA; group 2 included four patients in stage IIB, six in stage III, and two in stage IV. All patients underwent detailed cardiopulmonary evaluations at rest using electrocardiogram, echocardiogram, spirometry, and measurement of pulmonary diffusing capacity (DLCO), and during exercise using a cardiopulmonary exercise test. Groups 1 and 2 were similar with respect to sex distribution (eight women and four men in each), mean age (35±36 vs37±4.6 years), body mass index, and hemoglobin concentration (12.7±0.2 vs 12.1±0.3 g l−1). All patients had a normal cardiovascular status. All patients in group 1 had normal cardiorespiratory measurements at rest and during exercise. Forced vital capacity was significantly lower in group 2 (84.8±2.7% predicted) than in group 1 (105±3%, P<0.0001), without abnormalities in DLCO or in resting and exercise oxygen diffusion. Likewise, percentage predicted \(V_{{{\text{O}}_{{2\max }} }} \) (65±4 vs 97±6, P<0.0002), oxygen pulse at peak exercise (0.12±0.01 vs 0.17±0.01, P<0.001), and \({\Delta V_{{{\text{O}}_{{\text{2}}} }} } \mathord{\left/ {\vphantom {{\Delta V_{{{\text{O}}_{{\text{2}}} }} } {\Delta {\text{W}}}}} \right. \kern-\nulldelimiterspace} {\Delta {\text{W}}}\) slope (8.4±0.3 vs 10.2±0.4, P<0.003) were significantly lower in group 2 than in group 1. Functional capacity during exercise was markedly reduced in patients suffering from Hodgkin’s disease in advanced stages. This loss of exercise capacity appeared mainly related to a peripheral disorder.
Literature
1.
go back to reference Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, Greenbaum N, Mauch P, Lipshultz SE (2004) Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy. J Clin Oncol 22:3139–3148PubMedCrossRef Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, Greenbaum N, Mauch P, Lipshultz SE (2004) Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy. J Clin Oncol 22:3139–3148PubMedCrossRef
2.
go back to reference Aleman BM, Van den Belt-Dusebout AW, Klokman WJ, Van’t Veer MB, Bartelink H, Van Leeuwen FE (2003) Long-term cause-specific mortality of patients treated for Hodgkin’s disease. J Clin Oncol 21:3431–3439PubMedCrossRef Aleman BM, Van den Belt-Dusebout AW, Klokman WJ, Van’t Veer MB, Bartelink H, Van Leeuwen FE (2003) Long-term cause-specific mortality of patients treated for Hodgkin’s disease. J Clin Oncol 21:3431–3439PubMedCrossRef
3.
go back to reference Clark AL, Sparrow JL, Coats AJ (1995) Muscle fatigue and dyspnea in chronic heart failure: two sides of the same coin? Eur Heart J 16:49–52PubMed Clark AL, Sparrow JL, Coats AJ (1995) Muscle fatigue and dyspnea in chronic heart failure: two sides of the same coin? Eur Heart J 16:49–52PubMed
4.
go back to reference Dandurand RJ, Matthews PM, Arnold DL, Eidelman DH (1995) Mitochondrial disease. Pulmonary function, exercise performance, and blood lactate levels. Chest 108:182–189PubMed Dandurand RJ, Matthews PM, Arnold DL, Eidelman DH (1995) Mitochondrial disease. Pulmonary function, exercise performance, and blood lactate levels. Chest 108:182–189PubMed
5.
go back to reference Dimeo F, Schmittel A, Fietz T, Schwartz S, Köhler P, Böning D, Thiel E (2004) Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann Oncol 15:1237–1242PubMedCrossRef Dimeo F, Schmittel A, Fietz T, Schwartz S, Köhler P, Böning D, Thiel E (2004) Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann Oncol 15:1237–1242PubMedCrossRef
6.
go back to reference Durstine JL, Painter P, Franklin BA, Morgan D, Pitetti KH, Roberts SO (2000) Physical activity for the chronically ill and disabled. Sports Med 30:207–219PubMedCrossRef Durstine JL, Painter P, Franklin BA, Morgan D, Pitetti KH, Roberts SO (2000) Physical activity for the chronically ill and disabled. Sports Med 30:207–219PubMedCrossRef
7.
go back to reference Flaherty KR, Wald J, Weisman IM, Zeballos RJ, Schork MA, Blaivas M, Rubenfire M, Martinez FJ (2001) Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 164:425–432PubMed Flaherty KR, Wald J, Weisman IM, Zeballos RJ, Schork MA, Blaivas M, Rubenfire M, Martinez FJ (2001) Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 164:425–432PubMed
8.
go back to reference Ganz PA, Moinpour CM, Pauler DK, Kornblith AB, Gaynor ER, Balcerzak SP, Gatti GS, Erba HP, McCoy S, Press OW, Fisher RI (2003) Health status and quality of life in patients with early-stage Hodgkin’s disease treated on Southwest Oncology Group Study 9133. J Clin Oncol 21:3512–3519PubMedCrossRef Ganz PA, Moinpour CM, Pauler DK, Kornblith AB, Gaynor ER, Balcerzak SP, Gatti GS, Erba HP, McCoy S, Press OW, Fisher RI (2003) Health status and quality of life in patients with early-stage Hodgkin’s disease treated on Southwest Oncology Group Study 9133. J Clin Oncol 21:3512–3519PubMedCrossRef
9.
go back to reference Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnitter I (2003) Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 42:743–749PubMedCrossRef Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnitter I (2003) Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 42:743–749PubMedCrossRef
10.
go back to reference Kaufmann SH, Earnshaw WC (2000) Induction of apoptosis by cancer chemotherapy. Exp Cell Res 10:42–49CrossRef Kaufmann SH, Earnshaw WC (2000) Induction of apoptosis by cancer chemotherapy. Exp Cell Res 10:42–49CrossRef
11.
go back to reference Knobel H, Loge JH, Lund MB, Forfang K, Nome O, Kaasa S (2001) Late medical complications and fatigue in Hodgkin’s disease survivors. J Clin Oncol 19:3226–3233PubMed Knobel H, Loge JH, Lund MB, Forfang K, Nome O, Kaasa S (2001) Late medical complications and fatigue in Hodgkin’s disease survivors. J Clin Oncol 19:3226–3233PubMed
12.
go back to reference Loge JH, Abrahamsen AF, Ekeber O, Kaasa S (1999) Hodgkin’s disease survivors more fatigued than the general population. J Clin Oncol 17:253–261PubMed Loge JH, Abrahamsen AF, Ekeber O, Kaasa S (1999) Hodgkin’s disease survivors more fatigued than the general population. J Clin Oncol 17:253–261PubMed
13.
go back to reference Oldervoll LM, Kaasa S, Knobel H, Loge JH (2003) Exercise reduces fatigue in chronic fatigued Hodgkin’s disease survivors—results from a pilot study. Eur J Cancer 39:57–63PubMedCrossRef Oldervoll LM, Kaasa S, Knobel H, Loge JH (2003) Exercise reduces fatigue in chronic fatigued Hodgkin’s disease survivors—results from a pilot study. Eur J Cancer 39:57–63PubMedCrossRef
14.
go back to reference Ruffer JU, Flechtner H, Tralls P, Josting A, Sieber M, Lathan B, Diehl V, German Hodgkin Lymphoma Study Group (2003) Fatigue in long-term survivors of Hodgkin’s lymphoma: a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 39:2179–2186PubMedCrossRef Ruffer JU, Flechtner H, Tralls P, Josting A, Sieber M, Lathan B, Diehl V, German Hodgkin Lymphoma Study Group (2003) Fatigue in long-term survivors of Hodgkin’s lymphoma: a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 39:2179–2186PubMedCrossRef
15.
go back to reference Seymour JF, Talpaz M, Hagemeister FB, Cabanillas F, Kurzrock R (1997) Clinical correlates of elevated serum levels in interleukin 6 in patients with untreated Hodgkin’s disease. Am J Med 102:21–28PubMedCrossRef Seymour JF, Talpaz M, Hagemeister FB, Cabanillas F, Kurzrock R (1997) Clinical correlates of elevated serum levels in interleukin 6 in patients with untreated Hodgkin’s disease. Am J Med 102:21–28PubMedCrossRef
16.
go back to reference Villani F, Villani S, Bonfante V, De Maria P, Soncini F, Laffranchi A (2000) Late pulmonary effects in favorable stage I and IIA Hodgkin’s disease treated with radiotherapy alone. Am J Clin Oncol 23:18–21PubMedCrossRef Villani F, Villani S, Bonfante V, De Maria P, Soncini F, Laffranchi A (2000) Late pulmonary effects in favorable stage I and IIA Hodgkin’s disease treated with radiotherapy alone. Am J Clin Oncol 23:18–21PubMedCrossRef
17.
go back to reference Villani F, Fede Catania A, Laffranchi A, Maffioli L, Viviani S, Bonfante V (2003) Effect of an intensive chemotherapy followed by mediastinal irradiation on pulmonary and cardiac function in advanced Hodgkin’s disease. Cancer Invest 21:185–192PubMedCrossRef Villani F, Fede Catania A, Laffranchi A, Maffioli L, Viviani S, Bonfante V (2003) Effect of an intensive chemotherapy followed by mediastinal irradiation on pulmonary and cardiac function in advanced Hodgkin’s disease. Cancer Invest 21:185–192PubMedCrossRef
18.
go back to reference Wasserman K, Hansen JE, Sue DY et al (1994) Protocols for exercise testing. In: Wasserman K (ed) Principles of exercise testing and interpretation: including pathophysiology and clinical applications, 2nd edn. Lea & Febiger, Philadelphia, pp 58–71 Wasserman K, Hansen JE, Sue DY et al (1994) Protocols for exercise testing. In: Wasserman K (ed) Principles of exercise testing and interpretation: including pathophysiology and clinical applications, 2nd edn. Lea & Febiger, Philadelphia, pp 58–71
19.
go back to reference Weisman IM, Zaballos RJ (2002) An integrative approach to the interpretation of cardiopulmonary exercise testing. Prog Respir Res 32:300–322CrossRef Weisman IM, Zaballos RJ (2002) An integrative approach to the interpretation of cardiopulmonary exercise testing. Prog Respir Res 32:300–322CrossRef
Metadata
Title
Stage-related changes in functional capacity in Hodgkin’s disease: assessment by cardiopulmonary exercise testing before initiation of treatment
Authors
Eric Page
David Assouline
Catherine Durand
Odile Brun
David Coeffic
Danièle Fric
Claire Garnier
Cécile Leyronnas
Véronique Alcalay
Bernard Aguilaniu
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 12/2006
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-006-0174-5

Other articles of this Issue 12/2006

Annals of Hematology 12/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine